Sigyn Therapeutics, Inc. Quarterly report [Sections 13 or 15(d)]

Quarterly report [Sections 13 or 15(d)]

CONVERTIBLE PROMISSORY DEBENTURES (Tables)

CONVERTIBLE PROMISSORY DEBENTURES (Tables)

3 Months Ended

Mar. 31, 2025

Convertible notes payable consisted of the following:

Note Holder/Original Issuance Date	Maturity Date	Cash Received		Outstanding Balance as of March 31, 2025			Outstanding Balance as of December 31, 2024
Osher Capital Partners LLC
January 28, 2020 (“Note 1”)	August 31, 2025	$	350,005	$	620,553		$	620,553
June 22, 2022 (“Note 2”)	August 31, 2025		75,000		103,745			103,745
August 31, 2022 (“Note 2”)	August 31, 2025		100,000		135,520			135,520
September 20, 2022 (“Note 2”)	August 31, 2025		100,000		135,520			135,520
October 20, 2022 (“Note 2”)	March 31, 2025		100,000		127,000			127,000
November 14, 2022 (“Note 2”)	March 31, 2025		50,000		64,350			64,350
December 22, 2022 (“Note 2”)	March 31, 2025		100,000		125,000			125,000
July 18, 2023 (“Note 3”)	August 31, 2025		60,000		72,600			72,600
December 7, 2023 (“Note 3”)	August 31, 2025		40,000		48,400			48,400
May 13, 2024 (“Note 4”)	May 13, 2025		35,000		40,000			40,000
August 19, 2024 (“Note 4”)	August 19, 2025		7,500		8,250			8,250
November 19, 2024 (“Note 4”)	November 19, 2025		8,000		8,800			8,800

Brio Capital Master Fund, Ltd.
March 23, 2022 (“Note 2”)	August 31, 2025		100,000		142,960			142,960
November 9, 2022 (“Note 2”)	August 31, 2025		75,000		101,640			101,640
January 20, 2023 (“Note 3”)	March 31, 2025		50,000		62,500			62,500
February 9, 2023 (“Note 3”)	March 31, 2025		50,000		62,500			62,500
July 20, 2023 (“Note 3”)	August 31, 2025		40,000		48,400			48,400
January 8, 2024 (“Note 4”)	January 8, 2025		40,000		44,000			44,000
May 13, 2024 (“Note 4”)	May 13, 2025		35,000		40,000			40,000
August 20, 2024 (“Note 4”)	August 20, 2025		11,500		12,650			12,650
November 19, 2024 (“Note 4”)	November 19, 2025		8,000		8,800			8,800

Various third-party noteholders
Various dates in fiscal 2024 (“Note 4”)	November 19, 2025		650,890		8,800			8,800

FY 2025 Regulation D	Primarily January 9, 2026		345,197		379,717			-
Total convertible notes payable		$	2,431,092	$	2,401,705		$	2,021,988
Original issue discount					(96,749	)		(117,868	)
Debt discount					(115,660	)		(12,384	)

Total convertible notes payable				$	2,189,296		$	1,891,736

SCHEDULE OF PRINCIPAL PAYMENTS DUE ON CONVERTIBLE PROMISSORY DEBENTURES

Principal payments on convertible promissory debentures are due as follows:

Year ending December 31,
2025 (excluding the three months ended March 31, 2025)	$	2,021,988
2026		379,717
Long-Term Debt	$	2,401,705

SCHEDULE OF CHANGES IN NOTE DISCOUNTS

Changes in convertible notes were as follows:

	Note 1			Note 2			Note 3			Note 4			Reg D		Totals
Convertible notes payable as of December 31, 2022	$	700,816		$	1,578,500		$	-		$	-		$	-	$	2,279,316
Convertible notes payable issued in 2023		163,320			142,000			1,443,200			-			-		1,748,520
Conversion of debt for common stock		-			(341,000	)		(1,179,200	)		-			-		(1,520,200	)
Convertible notes payable as of December 31, 2023	$	864,136		$	1,379,500		$	264,000		$	-		$	-	$	2,507,636

Convertible notes payable issued in 2024		56,416			97,655			30,400			879,029			-		1,063,500
Conversion of debt for common stock		(299,999	)		(541,419	)		-			(707,730	)		-		(1,549,148	)
Convertible notes payable as of December 31, 2024	$	620,553		$	935,736		$	294,400		$	171,299		$	-	$	2,021,988
Convertible notes payable as of beginning balance	$	620,553		$	935,736		$	294,400		$	171,299		$	-	$	2,021,988

Convertible notes payable issued in 2025		-			-			-			-			379,717		379,717
Conversion of debt for common stock		-			-			-			-			-		-
Convertible notes payable as of March 31, 2025	$	620,553		$	935,736		$	294,400		$	171,299		$	379,717	$	2,401,705
Convertible notes payable as of ending balance	$	620,553		$	935,736		$	294,400		$	171,299		$	379,717	$	2,401,705

SCHEDULE OF CHANGES IN NOTE DISCOUNTS

Changes in note discounts were as follows:

	Note 1			Note 2			Note 3			Note 4			Reg D			Totals
Note discounts as of December 31, 2023	$	114,995		$	100,810		$	81,532		$	-		$	-		$	297,337

Note discounts issued in conjunction with debt in 2024		56,414			97,657			30,400			487,771			-			672,242
2024 accretion of note discounts		(129,214	)		(145,792	)		(95,981	)		(468,340	)		-			(839,327	)
Note discounts as of December 31, 2024	$	42,195		$	52,675		$	15,951		$	19,431		$	-		$	130,252
Note discounts as of beginning balance	$	42,195		$	52,675		$	15,951		$	19,431		$	-		$	130,252

Note discounts issued in conjunction with debt in 2025		-			-			-			-			165,500			165,500
Note discounts issued in conjunction with debt		-			-			-			-			165,500			165,500
2025 accretion of note discounts		(13,910	)		(24,080	)		(7,496	)		(7,053	)		(30,804	)		(83,343	)
Note discounts as of March 31, 2025	$	28,285		$	28,595		$	8,455		$	12,378		$	134,696		$	212,409
Note discounts as of ending balance	$	28,285		$	28,595		$	8,455		$	12,378		$	134,696		$	212,409

Convertible notes payable, net, as of Dec 31, 2024	$	578,358		$	883,061		$	278,449		$	151,868		$	-		$	1,891,736
Convertible notes payable, net, as of March 31, 2025	$	592,268		$	907,141		$	285,945		$	158,921		$	245,021		$	2,189,296
Convertible notes payable, net	$	592,268		$	907,141		$	285,945		$	158,921		$	245,021		$	2,189,296

2024 Effective interest rate		21	%		16	%		33	%		273	%		-%			42	%
2025 Effective interest rate		2	%		3	%		3	%		4	%		8	%		3	%